2138 Share Price Performance
Recent 2138 News & Updates
No updates
EC Healthcare Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.14
- Gross Margin
- 29.92%
- Net Profit Margin
- -4.05%
- Debt/Equity Ratio
- 36.1%
EC Healthcare Competitors
About 2138
- Founded
- 2005
- Employees
- 2872
- CEO
- WebsiteView website
EC Healthcare, an investment holding company, engages in the provision of medical and healthcare services in Hong Kong, Macau, and the People’s Republic of China. The company operates through Medical, Aesthetic Medical and Beauty and Wellness, Veterinary and Other segments. It also offers quasi-medical, beauty and wellness, medical imaging, medical surgery, aesthetic medical beauty, aesthetic medical, dental, eye and hair treatment, vaccine, and chiropractic services. In addition, the company provides administrative, management, laboratory testing, marketing, and travel agency services; sells beauty and skincare products; operates in healthcare machines and property investment holding businesses; and provides multi-channel networking and related services, and veterinary services. Further, it offers rehabilitation and cancer diagnosis services, as well as involved in leasing and hospital related services, and owns trademarks. EC Healthcare offers products and services primarily under private-label brands, such as PRODERMA LAB, Swissline, Suissebeaute, and re:HEALTH. The company was formerly known as Union Medical Healthcare Limited and changed its name to EC Healthcare in April 2021. EC Healthcare was founded in 2005 and is headquartered in Quarry Bay, Hong Kong.
Hong Kong Market Performance
- 7 Days: -3.1%
- 3 Months: 13.4%
- 1 Year: 38.8%
- Year to Date: 25.5%
Over the last 7 days, the market has dropped 3.1%, driven by a loss of 3.3% in the Financials sector. In the last year, the market is actually up 39%. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading